Prevention and treatment of cisplatin‐induced ototoxicity in adults: A systematic review
Clinical Otolaryngology · 2024
DOI: 10.1111/coa.14106 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Otolaryngology, 2024. Verfasst von Juan Esteban Correa-Morales und 8 weiteren Autor:innen. Beteiligte Einrichtung: Palliative Care Program, Universidad de La Sabana, Bogotá, Colombia. Hauptthemen laut MEDLINE: Antineoplastic Agents, Ototoxicity, Hearing Loss, Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
Objectives
Ototoxicity is a common disabling side effect of platinum‐based chemotherapy. This study aimed to assess the evidence on the management of platinum‐induced ototoxicity in adult cancer patients.
Methods
Four databases were searched up to 1 November 2022. Original studies were included if they reported on a pharmacologic or non‐pharmacologic intervention to prevent or treat platinum ototoxicity in adults. The articles' quality was assessed via two grading scales.
Results
Nineteen randomised controlled trials and five quasi‐experimental studies with 1673 patients were analysed. Eleven interventions were identified, nine pharmacological and two non‐pharmacological. Six of the interventions (sodium thiosulphate, corticoids, sertraline, statins, multivitamins and D‐methionine) showed mild benefits in preventing cisplatin‐induced ototoxicity. Only one trial assessed corticoids as a potential treatment. Overall, only six trials were deemed with a low risk of bias. The majority of studies inadequately documented intervention‐related adverse effects, thereby limiting safety conclusions.
Conclusions
Current interventions have mild benefits in preventing cisplatin‐induced ototoxicity in adult cancer patients. Sodium thiosulphate is the most promising intervention as a preventive strategy. Rigorous, high‐quality research is warranted, encompassing an evaluation of all potential symptoms and innovative treatment modalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Palliative Care Program, Universidad de La Sabana, Bogotá, Colombia.
- Instituto Nacional de Cancerología, Bogotá, Colombia.
- Universidad CES, Medellín, Colombia.
- University New Mexico, Albuquerque, New Mexico, USA.
ORCID-Profile: Juan Esteban Correa-Morales
Zitieren
APA
Correa-Morales, J. E., Giraldo-Moreno, S., Mantilla-Manosalva, N., Cuellar-Valencia, L., Borja-Montes, O. F., Bedoya-Muñoz, L. J., Iriarte-Aristizábal, M. F., Quintero-Muñoz, E., & Zuluaga-Liberato, A. M. (2024). Prevention and treatment of cisplatin‐induced ototoxicity in adults: A systematic review. Clinical Otolaryngology. https://doi.org/10.1111/coa.14106
Vancouver
Correa-Morales JE, Giraldo-Moreno S, Mantilla-Manosalva N, Cuellar-Valencia L, Borja-Montes OF, Bedoya-Muñoz LJ, et al. Prevention and treatment of cisplatin‐induced ototoxicity in adults: A systematic review. Clinical Otolaryngology. 2024. doi:10.1111/coa.14106
BibTeX
@article{CorreaMorales2024,
author = {Correa-Morales, Juan Esteban and Giraldo-Moreno, Sara and Mantilla-Manosalva, Nidia and Cuellar-Valencia, Laura and Borja-Montes, Oscar Felipe and Bedoya-Muñoz, Lennis Jazmin and Iriarte-Aristizábal, María Fernanda and Quintero-Muñoz, Elias and Zuluaga-Liberato, Andrea Marcela},
title = {Prevention and treatment of cisplatin‐induced ototoxicity in adults: A systematic review},
journal = {Clinical Otolaryngology},
year = {2024},
doi = {10.1111/coa.14106}
}
EUVIMED